1130049

Acorda Therapeutics, Inc. — FEI 3002457563

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 18, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pearl River, NY (United States)